Pill imprint N S1 has been identified as Sucralfate 1 g.
Sucralfate is used in the treatment of stomach ulcer; gerd; hyperphosphatemia of renal failure; duodenal ulcer; stomatitis (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy.
Sucralfate 1 g is not subject to the Controlled Substances Act.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.